Cargando…

Deep learning model for distinguishing Mayo endoscopic subscore 0 and 1 in patients with ulcerative colitis

The aim of this study was to address the issue of differentiating between Mayo endoscopic subscore (MES) 0 and MES 1 using a deep learning model. A dataset of 492 ulcerative colitis (UC) patients who demonstrated MES improvement between January 2018 and December 2019 at Samsung Medical Center was ut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Eun, Choi, Yoon Ho, Lee, Yeong Chan, Seong, Gyeol, Song, Joo Hye, Kim, Tae Jun, Kim, Eun Ran, Hong, Sung Noh, Chang, Dong Kyung, Kim, Young-Ho, Shin, Soo-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344868/ https://www.ncbi.nlm.nih.gov/pubmed/37443370 http://dx.doi.org/10.1038/s41598-023-38206-6

Ejemplares similares

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
por: Lee, Sun-Ho, et al.
Publicado: (2017)

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
por: Lee, Scott D., et al.
Publicado: (2023)

The 2 + 1 paradigm: an efficient algorithm for central reading of Mayo endoscopic subscores in global multicenter phase 3 ulcerative colitis clinical trials
por: Ahmad, Harris A., et al.
Publicado: (2016)

Incremental Detection Rate of Dysplasia and Sessile Serrated Polyps/Adenomas Using Narrow-Band Imaging and Dye Spray Chromoendoscopy in Addition to High-Definition Endoscopy in Patients with Long-Standing Extensive Ulcerative Colitis: Segmental Tandem Endoscopic Study
por: Kim, Ji Eun, et al.
Publicado: (2023)

Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
por: Viscido, Angelo, et al.
Publicado: (2022)

Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission
por: Shin, Jongbeom, et al.
Publicado: (2021)

Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study
por: Shah, Jimil, et al.
Publicado: (2019)

Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis
por: Xie, Tingbin, et al.
Publicado: (2018)

Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis
por: Qi, Jing, et al.
Publicado: (2023)

The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014)

Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study
por: Nam, Kwangwoo, et al.
Publicado: (2021)

Recurrent Mesalazine-Induced Myopericarditis in a Patient with Ulcerative Colitis
por: Park, Eun Hye, et al.
Publicado: (2012)

The Use of Subscores in Higher Education: When Is This Useful?
por: Meijer, Rob R., et al.
Publicado: (2017)

Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
por: Belvis Jiménez, María, et al.
Publicado: (2021)

Pulmonary Toxocariasis Mimicking Invasive Aspergillosis in a Patient with Ulcerative Colitis
por: Park, Eun Jin, et al.
Publicado: (2014)

Effect of the stellate ganglion block on symptoms of ulcerative colitis: A case report
por: Kim, Young Shin, et al.
Publicado: (2021)

Is Long-Term Therapy With Thiopurines Effective for Maintaining Remission in Patients With Moderate-To-Severe Ulcerative Colitis?
por: Jeon, Seong Ran, et al.
Publicado: (2015)

Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
por: Park, Su Bum, et al.
Publicado: (2022)

Time-adjusted average Mayo endoscopic score predicts the risk of disease extent progression in distal ulcerative colitis patients
por: Wan, Jian, et al.
Publicado: (2022)

Usefulness of Examining Various Patient-Reported Outcomes in Predicting Endoscopic Mucosal Healing in Ulcerative Colitis
por: Min Moon, Jung, et al.
Publicado: (2022)

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study
por: Kim, Eun Hye, et al.
Publicado: (2015)

Corrigendum: The Use of Subscores in Higher Education: When Is This Useful?
por: Meijer, Rob R., et al.
Publicado: (2018)

Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
por: Yu, Jongwook, et al.
Publicado: (2021)

Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
por: Lee, Hae Chan, et al.
Publicado: (2023)

Current practices in endoscopic submucosal dissection for colorectal neoplasms: a survey of indications among Korean endoscopists
por: Kim, Tae Jun, et al.
Publicado: (2017)

Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program
por: Sandborn, William J., et al.
Publicado: (2022)

Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
por: Lee, Jin Wook, et al.
Publicado: (2021)

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system
por: Bálint, Anita, et al.
Publicado: (2018)

Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle
por: Seong, Gyeol, et al.
Publicado: (2020)

T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients
por: Nam, Seung-Joo, et al.
Publicado: (2018)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Clinical Characteristics and Incidence of Perianal Diseases in Patients With Ulcerative Colitis
por: Choi, Yong Sung, et al.
Publicado: (2018)

Diffuse Involvement of Primary Colorectal Lymphoma Simulating Ulcerative Colitis
por: Kim, Ji-Ye, et al.
Publicado: (2019)

A Genome-Wide Methylation Approach Identifies a New Hypermethylated Gene Panel in Ulcerative Colitis
por: Kang, Keunsoo, et al.
Publicado: (2016)

Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis
por: Goll, Rasmus, et al.
Publicado: (2019)

The Mayo Endoscopic Score Is a Novel Predictive Indicator for Malignant Transformation in Ulcerative Colitis: A Long-Term Follow-Up Multicenter Study
por: Xu, Weimin, et al.
Publicado: (2022)

Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
por: Chun, Jaeyoung, et al.
Publicado: (2015)

A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis
por: Kawakatsu, Sonoko, et al.
Publicado: (2021)

Development of a Machine Learning Model to Distinguish between Ulcerative Colitis and Crohn’s Disease Using RNA Sequencing Data
por: Park, Soo-Kyung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0bnbh8hc8rd8mbvhqdpuu8hbmc